Frontlight ResearchEarly access
Trial site
Hospital Germans Trials i Pujol
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma2 trials
- Phase
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- PETHEMA Foundation2 trials
Running trials
Active, not recruiting
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
Active, not recruiting
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
Site data: ClinicalTrials.govUpdated 12 Nov 2026